Exencial Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,912
Closed -$1.41M 577
2025
Q4
$1.41M Buy
+13,912
New +$1.12M 0.04% 255
2023
Q3
Sell
-2,219
Closed -$208K 427
2023
Q2
$208K Buy
+2,219
New +$173K 0.01% 413
2022
Q2
Sell
-3,489
Closed -$244K 432
2022
Q1
$244K Sell
3,489
-2,822
-45% -$206K 0.01% 393
2021
Q4
$491K Sell
6,311
-1,036
-14% -$91.4K 0.02% 316
2021
Q3
$701K Sell
7,347
-579
-7% -$61.1K 0.03% 216
2021
Q2
$985K Buy
7,926
+601
+8% +$71.7K 0.05% 231
2021
Q1
$965K Buy
7,325
+2,367
+48% +$324K 0.06% 222
2020
Q4
$657K Buy
4,958
+274
+6% +$33.1K 0.04% 221
2020
Q3
$478K Buy
4,684
+2,093
+81% +$181K 0.03% 260
2020
Q2
$225K Buy
+2,591
New +$207K 0.02% 301
2020
Q1
Sell
-2,194
Closed -$203K 248
2019
Q4
$203K Sell
2,194
-217
-9% -$19.1K 0.04% 258
2019
Q3
$218K Sell
2,411
-1,671
-41% -$190K 0.05% 230
2019
Q2
$482K Hold
4,082
0.11% 143
2019
Q1
$354K Buy
+4,082
New +$347K 0.08% 169

Other funds holding EXAS

Exencial Wealth Advisors's EXAS Position: Q1 2026 in Review

Exencial Wealth Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 13,912 shares — an estimated $1.41M sold.

Exencial Wealth Advisors first reported a position in EXAS in Q1 2019 and held it in 14 quarters. The position peaked at $1.41M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Exencial Wealth Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Exencial Wealth Advisors sold 13,912 Exact Sciences shares in Q1 2026, an estimated $1.41M.
  • Exencial Wealth Advisors first reported a position in Exact Sciences in Q1 2019 and held it in 14 quarters.
  • Exencial Wealth Advisors's Exact Sciences position peaked at $1.41M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.